Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HL06
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006520 | amino acid metabolic process | 3 | 1 |
GO:0006573 | valine metabolic process | 5 | 1 |
GO:0006574 | valine catabolic process | 6 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009063 | amino acid catabolic process | 4 | 1 |
GO:0009081 | branched-chain amino acid metabolic process | 4 | 1 |
GO:0009083 | branched-chain amino acid catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016054 | organic acid catabolic process | 4 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044282 | small molecule catabolic process | 3 | 1 |
GO:0046395 | carboxylic acid catabolic process | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
GO:1901605 | alpha-amino acid metabolic process | 4 | 1 |
GO:1901606 | alpha-amino acid catabolic process | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity | 6 | 12 |
GO:0016289 | CoA hydrolase activity | 5 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0016790 | thiolester hydrolase activity | 4 | 12 |
GO:0016829 | lyase activity | 2 | 6 |
GO:0016853 | isomerase activity | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 250 | 254 | PF00656 | 0.280 |
CLV_C14_Caspase3-7 | 344 | 348 | PF00656 | 0.237 |
CLV_PCSK_KEX2_1 | 288 | 290 | PF00082 | 0.320 |
CLV_PCSK_PC1ET2_1 | 288 | 290 | PF00082 | 0.444 |
CLV_PCSK_SKI1_1 | 198 | 202 | PF00082 | 0.144 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.294 |
CLV_PCSK_SKI1_1 | 216 | 220 | PF00082 | 0.119 |
CLV_PCSK_SKI1_1 | 289 | 293 | PF00082 | 0.261 |
CLV_PCSK_SKI1_1 | 321 | 325 | PF00082 | 0.219 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.299 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.476 |
DOC_ANK_TNKS_1 | 156 | 163 | PF00023 | 0.230 |
DOC_CKS1_1 | 217 | 222 | PF01111 | 0.237 |
DOC_CKS1_1 | 293 | 298 | PF01111 | 0.360 |
DOC_CYCLIN_yCln2_LP_2 | 293 | 299 | PF00134 | 0.237 |
DOC_MAPK_DCC_7 | 157 | 165 | PF00069 | 0.230 |
DOC_MAPK_gen_1 | 173 | 182 | PF00069 | 0.283 |
DOC_MAPK_MEF2A_6 | 157 | 165 | PF00069 | 0.230 |
DOC_MAPK_MEF2A_6 | 175 | 184 | PF00069 | 0.145 |
DOC_PP2B_LxvP_1 | 136 | 139 | PF13499 | 0.144 |
DOC_PP2B_LxvP_1 | 158 | 161 | PF13499 | 0.348 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.434 |
DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.263 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.429 |
DOC_USP7_UBL2_3 | 288 | 292 | PF12436 | 0.373 |
DOC_WW_Pin1_4 | 216 | 221 | PF00397 | 0.237 |
DOC_WW_Pin1_4 | 273 | 278 | PF00397 | 0.285 |
DOC_WW_Pin1_4 | 292 | 297 | PF00397 | 0.360 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.150 |
LIG_14-3-3_CanoR_1 | 128 | 136 | PF00244 | 0.209 |
LIG_14-3-3_CanoR_1 | 157 | 161 | PF00244 | 0.352 |
LIG_14-3-3_CanoR_1 | 21 | 26 | PF00244 | 0.260 |
LIG_14-3-3_CanoR_1 | 351 | 360 | PF00244 | 0.470 |
LIG_14-3-3_CanoR_1 | 44 | 50 | PF00244 | 0.425 |
LIG_14-3-3_CanoR_1 | 7 | 13 | PF00244 | 0.431 |
LIG_Actin_WH2_2 | 160 | 177 | PF00022 | 0.226 |
LIG_APCC_ABBA_1 | 143 | 148 | PF00400 | 0.219 |
LIG_eIF4E_1 | 17 | 23 | PF01652 | 0.275 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.144 |
LIG_FHA_1 | 184 | 190 | PF00498 | 0.285 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.389 |
LIG_FHA_1 | 241 | 247 | PF00498 | 0.241 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.364 |
LIG_FHA_1 | 279 | 285 | PF00498 | 0.312 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.448 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.324 |
LIG_FHA_2 | 293 | 299 | PF00498 | 0.407 |
LIG_FHA_2 | 335 | 341 | PF00498 | 0.250 |
LIG_FHA_2 | 351 | 357 | PF00498 | 0.386 |
LIG_LIR_Apic_2 | 152 | 156 | PF02991 | 0.212 |
LIG_LIR_Apic_2 | 215 | 220 | PF02991 | 0.237 |
LIG_LIR_Apic_2 | 347 | 352 | PF02991 | 0.259 |
LIG_LIR_Gen_1 | 337 | 346 | PF02991 | 0.202 |
LIG_LIR_Nem_3 | 232 | 236 | PF02991 | 0.438 |
LIG_LIR_Nem_3 | 337 | 341 | PF02991 | 0.175 |
LIG_SH2_CRK | 166 | 170 | PF00017 | 0.237 |
LIG_SH2_CRK | 217 | 221 | PF00017 | 0.237 |
LIG_SH2_NCK_1 | 217 | 221 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.215 |
LIG_SH2_STAT5 | 239 | 242 | PF00017 | 0.159 |
LIG_SH2_STAT5 | 304 | 307 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 349 | 352 | PF00017 | 0.301 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.215 |
LIG_SH3_3 | 356 | 362 | PF00018 | 0.295 |
LIG_SH3_3 | 44 | 50 | PF00018 | 0.319 |
LIG_SUMO_SIM_anti_2 | 243 | 250 | PF11976 | 0.144 |
LIG_SUMO_SIM_par_1 | 247 | 253 | PF11976 | 0.144 |
LIG_SUMO_SIM_par_1 | 280 | 285 | PF11976 | 0.406 |
LIG_UBA3_1 | 22 | 29 | PF00899 | 0.231 |
LIG_UBA3_1 | 248 | 256 | PF00899 | 0.239 |
LIG_WRC_WIRS_1 | 272 | 277 | PF05994 | 0.237 |
MOD_CK1_1 | 232 | 238 | PF00069 | 0.237 |
MOD_CK2_1 | 292 | 298 | PF00069 | 0.333 |
MOD_CK2_1 | 334 | 340 | PF00069 | 0.341 |
MOD_GlcNHglycan | 190 | 193 | PF01048 | 0.353 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.394 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.144 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.304 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.185 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.282 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.214 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.376 |
MOD_LATS_1 | 19 | 25 | PF00433 | 0.352 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.484 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.285 |
MOD_NEK2_2 | 52 | 57 | PF00069 | 0.231 |
MOD_PIKK_1 | 304 | 310 | PF00454 | 0.345 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.420 |
MOD_PKA_2 | 156 | 162 | PF00069 | 0.352 |
MOD_PKA_2 | 350 | 356 | PF00069 | 0.551 |
MOD_Plk_1 | 244 | 250 | PF00069 | 0.214 |
MOD_Plk_4 | 149 | 155 | PF00069 | 0.313 |
MOD_Plk_4 | 244 | 250 | PF00069 | 0.224 |
MOD_Plk_4 | 52 | 58 | PF00069 | 0.352 |
MOD_Plk_4 | 97 | 103 | PF00069 | 0.340 |
MOD_ProDKin_1 | 216 | 222 | PF00069 | 0.237 |
MOD_ProDKin_1 | 273 | 279 | PF00069 | 0.285 |
MOD_ProDKin_1 | 292 | 298 | PF00069 | 0.360 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.150 |
MOD_SUMO_for_1 | 300 | 303 | PF00179 | 0.144 |
MOD_SUMO_rev_2 | 191 | 200 | PF00179 | 0.144 |
MOD_SUMO_rev_2 | 91 | 100 | PF00179 | 0.233 |
TRG_DiLeu_BaLyEn_6 | 18 | 23 | PF01217 | 0.207 |
TRG_DiLeu_BaLyEn_6 | 260 | 265 | PF01217 | 0.144 |
TRG_ENDOCYTIC_2 | 166 | 169 | PF00928 | 0.301 |
TRG_ENDOCYTIC_2 | 239 | 242 | PF00928 | 0.365 |
TRG_NES_CRM1_1 | 241 | 253 | PF08389 | 0.144 |
TRG_NES_CRM1_1 | 37 | 49 | PF08389 | 0.144 |
TRG_Pf-PMV_PEXEL_1 | 321 | 326 | PF00026 | 0.212 |
TRG_Pf-PMV_PEXEL_1 | 369 | 373 | PF00026 | 0.318 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P500 | Leptomonas seymouri | 39% | 100% |
A0A0N0P5E1 | Leptomonas seymouri | 65% | 100% |
A0A1X0NSC5 | Trypanosomatidae | 45% | 100% |
A0A1X0NTE8 | Trypanosomatidae | 47% | 100% |
A0A1X0NTM5 | Trypanosomatidae | 47% | 100% |
A0A381MRJ9 | Leishmania infantum | 38% | 100% |
A0A3Q8IDG7 | Leishmania donovani | 38% | 100% |
A0A3Q8IHF8 | Leishmania donovani | 83% | 100% |
A0A3Q8ITQ0 | Leishmania donovani | 38% | 100% |
A2VDC2 | Xenopus laevis | 41% | 97% |
A4HL04 | Leishmania braziliensis | 40% | 100% |
A4HL05 | Leishmania braziliensis | 38% | 100% |
A4I8I5 | Leishmania infantum | 38% | 100% |
A4I8I6 | Leishmania infantum | 83% | 100% |
D0AAN2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E8NHQ8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 100% |
E9B3E6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
O74802 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 32% | 87% |
P28817 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 29% | 75% |
Q1PEY5 | Arabidopsis thaliana | 35% | 99% |
Q28FR6 | Xenopus tropicalis | 41% | 97% |
Q2HJ73 | Bos taurus | 38% | 97% |
Q4Q4Q4 | Leishmania major | 85% | 100% |
Q4Q4Q5 | Leishmania major | 38% | 100% |
Q4Q4Q6 | Leishmania major | 38% | 100% |
Q55GS6 | Dictyostelium discoideum | 33% | 98% |
Q58EB4 | Danio rerio | 38% | 98% |
Q5XF59 | Arabidopsis thaliana | 35% | 94% |
Q5XIE6 | Rattus norvegicus | 38% | 97% |
Q5ZJ60 | Gallus gallus | 38% | 97% |
Q6NMB0 | Arabidopsis thaliana | 36% | 99% |
Q6NVY1 | Homo sapiens | 37% | 97% |
Q8QZS1 | Mus musculus | 38% | 97% |
Q8RXN4 | Arabidopsis thaliana | 32% | 92% |
Q9LK08 | Arabidopsis thaliana | 31% | 90% |
Q9LKJ1 | Arabidopsis thaliana | 36% | 99% |
Q9SHJ8 | Arabidopsis thaliana | 32% | 97% |
Q9T0K7 | Arabidopsis thaliana | 33% | 89% |
V5BQZ7 | Trypanosoma cruzi | 44% | 97% |